Search research articles
Contact Us
Filters
Showing results (11-20 of 120) with videos related to
Page
of 12
Sort By:
Annals of the Rheumatic Diseases
|
April 3, 2024
Response to: Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update' by Hellmich <i>et al</i>
Bernhard Hellmich, David Jayne
Innere Medizin (Heidelberg, Germany)
|
January 22, 2024
[Management of ANCA-associated vasculitides]
Christian Löffler, Bernhard Hellmich
Deutsche Medizinische Wochenschrift (1946)
|
September 12, 2015
[Fever, skin changes, myalgia - from early symptom to diagnosis]
Bastian Walz, Bernhard Hellmich
Autoimmunity Reviews
|
March 16, 2020
Usefulness of vasculitis biomarkers in the era of the personalized medicine
Elena Csernok, Bernhard Hellmich
Clinical and Experimental Rheumatology
|
March 17, 2026
Combination of rituximab and cyclophosphamide for induction of remission in ANCA-associated vasculitis: the stronger, the better?
Bernhard Hellmich, Christian Löffler
Der Internist
|
January 14, 2022
[Biologics for connective tissue diseases and vasculitides]
Bernhard Hellmich, Joerg C Henes
Expert Opinion on Investigational Drugs
|
October 2, 2003
The Annual European Congress of Rheumatology: recent advances in the treatment of rheumatic diseases. Lisbon, Portugal, June 18-21, 2003
Bernhard Hellmich, Wolfgang L Gross
Best Practice & Research. Clinical Rheumatology
|
April 29, 2005
Difficult to diagnose manifestations of vasculitis: does an interdisciplinary approach help?
Bernhard Hellmich, W L Gross
Expert Opinion on Pharmacotherapy
|
December 19, 2003
Recent progress in the pharmacotherapy of Churg-Strauss syndrome
Bernhard Hellmich, Wolfgang L Gross
Rheumatology (Oxford, England)
|
March 12, 2025
Highlights from the plenary session: advances in treatment (I)
Rona M Smith, Bernhard Hellmich
Page
of 12
Search research articles
Search
Showing results (11-20 of 120) with videos related to
Sort By:
Page
of 12
Annals of the Rheumatic Diseases
|
April 3, 2024
Response to: Correspondence on 'EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update' by Hellmich <i>et al</i>
Bernhard Hellmich, David Jayne
Innere Medizin (Heidelberg, Germany)
|
January 22, 2024
[Management of ANCA-associated vasculitides]
Christian Löffler, Bernhard Hellmich
Deutsche Medizinische Wochenschrift (1946)
|
September 12, 2015
[Fever, skin changes, myalgia - from early symptom to diagnosis]
Bastian Walz, Bernhard Hellmich
Autoimmunity Reviews
|
March 16, 2020
Usefulness of vasculitis biomarkers in the era of the personalized medicine
Elena Csernok, Bernhard Hellmich
Clinical and Experimental Rheumatology
|
March 17, 2026
Combination of rituximab and cyclophosphamide for induction of remission in ANCA-associated vasculitis: the stronger, the better?
Bernhard Hellmich, Christian Löffler
Der Internist
|
January 14, 2022
[Biologics for connective tissue diseases and vasculitides]
Bernhard Hellmich, Joerg C Henes
Expert Opinion on Investigational Drugs
|
October 2, 2003
The Annual European Congress of Rheumatology: recent advances in the treatment of rheumatic diseases. Lisbon, Portugal, June 18-21, 2003
Bernhard Hellmich, Wolfgang L Gross
Best Practice & Research. Clinical Rheumatology
|
April 29, 2005
Difficult to diagnose manifestations of vasculitis: does an interdisciplinary approach help?
Bernhard Hellmich, W L Gross
Expert Opinion on Pharmacotherapy
|
December 19, 2003
Recent progress in the pharmacotherapy of Churg-Strauss syndrome
Bernhard Hellmich, Wolfgang L Gross
Rheumatology (Oxford, England)
|
March 12, 2025
Highlights from the plenary session: advances in treatment (I)
Rona M Smith, Bernhard Hellmich
Page
of 12